ProVise Management Group’s Apyx Medical APYX Stock Holding History

ProVise Management Group’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-13,499	Closed	-$30.4K	–	260
2025 Q2	$30.4K	Hold	13,499	–	–	﹤0.01%	259
2025 Q1	$18.5K	Hold	13,499	–	–	﹤0.01%	249
2024 Q4	$21.3K	Hold	13,499	–	–	﹤0.01%	258
2024 Q3	$16.7K	Hold	13,499	–	–	﹤0.01%	296
2024 Q2	$18.1K	Hold	13,499	–	–	﹤0.01%	295
2024 Q1	$18.4K	Hold	13,499	–	–	﹤0.01%	298
2023 Q4	$35.4K	Buy	+13,499	New	+$32.7K	﹤0.01%	342
2023 Q2	–	Sell	-13,499	Closed	-$38.9K	–	345
2023 Q1	$38.9K	Hold	13,499	–	–	﹤0.01%	341
2022 Q4	$31.6K	Buy	+13,499	New	+$41.2K	﹤0.01%	317
2022 Q1	–	Sell	-111,189	Closed	-$1.43M	–	374
2021 Q4	$1.43M	Hold	111,189	–	–	0.13%	148
2021 Q3	$1.54M	Buy	111,189 +3,499	+3%	+$36.8K	0.15%	142
2021 Q2	$1.11M	Hold	107,690	–	–	0.11%	161
2021 Q1	$1.04M	Hold	107,690	–	–	0.11%	158
2020 Q4	$775K	Sell	107,690 -46,100	-30%	-$306K	0.09%	179
2020 Q3	$724K	Sell	153,790 -17,000	-10%	-$84.2K	0.1%	172
2020 Q2	$948K	Sell	170,790 -4,000	-2%	-$16.6K	0.14%	137
2020 Q1	$627K	Hold	174,790	–	–	0.11%	156
2019 Q4	$1.48M	Sell	174,790 -12,560	-7%	-$90.7K	0.18%	124
2019 Q3	$1.27M	Sell	187,350 -60,000	-24%	-$426K	0.17%	130
2019 Q2	$1.66M	Sell	247,350 -50,000	-17%	-$272K	0.22%	116
2019 Q1	$1.88M	Sell	297,350 -12,460	-4%	-$96.4K	0.26%	102
2018 Q4	$2.01M	Hold	309,810	–	–	0.32%	86
2018 Q3	$2.2M	Sell	309,810 -21,100	-6%	-$117K	0.29%	101
2018 Q2	$1.44M	Buy	+330,910	New	+$1.22M	0.11%	142

Other funds holding APYX

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SBCM

Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ProVise Management Group's APYX Position: Q3 2025 in Review

ProVise Management Group sold out of Apyx Medical (APYX) in Q3 2025, closing a stake of 13,499 shares — an estimated $30.4K sold.

ProVise Management Group first reported a position in APYX in Q2 2018 and held it in 24 quarters. The position peaked at $2.2M in Q3 2018. 47 funds tracked by Wall St. Rank hold APYX as of Q3 2025.

ProVise Management Group reported no remaining Apyx Medical position as of Q3 2025 after selling out during the quarter.
ProVise Management Group sold 13,499 Apyx Medical shares in Q3 2025, an estimated $30.4K.
ProVise Management Group first reported a position in Apyx Medical in Q2 2018 and held it in 24 quarters.
ProVise Management Group's Apyx Medical position peaked at $2.2M in Q3 2018.
47 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2025.

Based on ProVise Management Group's 13F filing for Q3 2025, filed 13 Nov 2025.